FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Epinephrine Injection, 1 mg/mL
Status: Resolved
»Duration of Shortage: 06/21/2012 - 02/03/2017
»Therapeutic Categories: Cardiovascular; Pulmonary/Allergy

Expand all

Amphastar Pharmaceuticals, Inc./IMS (New 02/03/2017)

Company Contact Information:
800-423-4136

Presentation
  • Epinephrine Inj. USP, 1mg/mL, 30mL vial (NDC 76329-9061-00)
Note:
  • Available

BPI Labs, LLC (New 02/03/2017)

Company Contact Information:
732-339-3573

Presentation
  • 1 mg/mL, 1 mL ampule, preservative-free, sulfite-free (NDC 54288-103-10)
Note:
  • Available

Hospira, Inc. (New 02/03/2017)

Company Contact Information:
877-946-7747

Presentation
  • 1 mg/mL, 1 mL ampule (NDC 0409-7241-01)
Note:
  • Available

Par Pharmaceutical (New 02/03/2017)

Company Contact Information:
201-802-4000

Presentation
  • Adrenalin® (epinephrine injection, USP) 1 mg/mL, 1 mL vial pack of 25 (NDC 42023-159-25)
  • Adrenalin® (epinephrine injection, USP) 1 mg/mL, 30 mL vial pack of 1 (NDC 42023-168-01)
Note:
  • Available

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English